SRPT
Sarepta Therapeutics,, Inc. Common Stock
stockNASDAQ
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 17.73 | 2026-10-23 | +3.95% | 2.633 |
| 1M | 17.57 | 2026-10-01 | +4.89% | 1.580 |
| 3M | 14.86 | 2026-07-31 | +24.02% | 2.287 |
| 6M | 21.49 | 2026-05-01 | -14.24% | 1.267 |
| 1Y | 24.01 | 2025-10-31 | -23.24% | 2.051 |
| 2Y | 126.00 | 2024-10-31 | -85.37% | — |
| 5Y | 80.06 | 2021-11-01 | -76.98% | 0.655 |
Sarepta Therapeutics,, Inc. Common Stock (NASDAQ:SRPT) stock price today is $18.43, and today's volume is 1,318,156. SRPT is down 4.160% today. The 30 day average volume is 2.64M. SRPT market cap is $1.95B with 105.63M shares outstanding.